Researchmoz added Most up-to-date research on "Global Non-Invasive Prenatal Testing Market 2016-2020" to its huge collection of research reports.
NIPT is an advanced technology that helps detect fatal chromosomal aneuploidies by analyzing the fetus' cell-free DNA. It also helps diagnose the risks for genetic disorders such as Down, Turner, Klinefelter, and XYY syndromes, which are common sex chromosomal aneuploidies associated with reproductive loss, infertility, and language development delays. Since its introduction into clinical practice in Hong Kong in 2011, NIPT has rapidly spread across the world.
Technavios analysts forecast the global non-invasive prenatal testing (NIPT) market to grow at a CAGR of 17.44% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global non-invasive prenatal testing (NIPT) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of testing products.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=810443
Technavio's report, Global Non-Invasive Prenatal Testing (NIPT) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
BGI Genomics
Illumina
LifeCodexx
Natera
Sequenom
Other prominent vendors
Ariosa Diagnostics
Berry Genomics
CombiMatrix
F. Hoffmann-La Roche
Genpharm Services
Laboratory Corporation of America Holdings
LifeLabs Genetics
Quest Diagnostics
Safembryo
Sengenics
Market driver
Incidence of fetal chromosomal disorders in newborns
For a full, detailed list, view our report
Market challenge
Limited consumer options and lack of effective product differentiation
For a full, detailed list, view our report
Market trend
Increase in partnerships and collaborations
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=810443
NIPT is an advanced technology that helps detect fatal chromosomal aneuploidies by analyzing the fetus' cell-free DNA. It also helps diagnose the risks for genetic disorders such as Down, Turner, Klinefelter, and XYY syndromes, which are common sex chromosomal aneuploidies associated with reproductive loss, infertility, and language development delays. Since its introduction into clinical practice in Hong Kong in 2011, NIPT has rapidly spread across the world.
Technavios analysts forecast the global non-invasive prenatal testing (NIPT) market to grow at a CAGR of 17.44% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global non-invasive prenatal testing (NIPT) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of testing products.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=810443
Technavio's report, Global Non-Invasive Prenatal Testing (NIPT) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
BGI Genomics
Illumina
LifeCodexx
Natera
Sequenom
Other prominent vendors
Ariosa Diagnostics
Berry Genomics
CombiMatrix
F. Hoffmann-La Roche
Genpharm Services
Laboratory Corporation of America Holdings
LifeLabs Genetics
Quest Diagnostics
Safembryo
Sengenics
Market driver
Incidence of fetal chromosomal disorders in newborns
For a full, detailed list, view our report
Market challenge
Limited consumer options and lack of effective product differentiation
For a full, detailed list, view our report
Market trend
Increase in partnerships and collaborations
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=810443
No comments:
Post a Comment